For the Inventor, By the Inventor

Enter assignee name

København, Denmark

Veloxis Pharmaceuticals A/s

USPTO Granted Patents = 24

CIPO Patents = 4

EPO Patents = 6

Trademarks = 8

Forward Citations = 143

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Per Holm (22 out of 36 patents)

Tomas Norling (14 out of 22 patents)

Robert D Gordon (3 out of 15 patents)

4. Anne-Marie Lademann (3 out of 6 patents)

5. William J Polvino (2 out of 15 patents)

6. Nikolaj Skak (2 out of 8 patents)

7. Anders Burr (2 out of 2 patents)

8. Michiel Ringkjøbing-elema (2 out of 2 patents)

9. Jannie Egeskov Holm (2 out of 3 patents)

10. Birgitte Møllgaard (2 out of 3 patents)

11. Kirsten Schultz (2 out of 3 patents)

12. Anne-Marie Lademann (4 patents)

13. Michiel Onne Elema (1 patent)

14. Birgitte Mollgaard (2 patents)

15. Per Holm (0 patent)

24 patents: Sort by Forward Citations

1. 10864199 - Tacrolimus for improved treatment of transplant patients (2020-12-15),

2. 10548880 - Solid dispersions comprising tacrolimus (2020-02-04),

3. 10485793 - Regimen for suppressing organ rejection (2019-11-26),

4. 10166190 - Stabilized tacrolimus composition (2019-01-01),

5. 9775834 - Regimen for supressing organ rejection (2017-10-03),

6. 9763920 - Solid dispersions comprising tacrolimus (2017-09-19),

7. 9757362 - Modified release compositions comprising tacrolimus (2017-09-12),

8. 9549918 - Stabilized tacrolimus composition (2017-01-24),

9. 9295653 - Controlled agglomeration (2016-03-29),

10. 9173847 - Tablet comprising a fibrate (2015-11-03),

11. 9161907 - Modified release compositions comprising tacrolimus (2015-10-20),

12. 8889186 - Modified release compositions comprising tacrolimus (2014-11-18),

13. 8889185 - Modified release compositions comprising tacrolimus (2014-11-18),

14. 8685998 - Tacrolimus for improved treatment of transplant patients (2014-04-01),

15. 8664239 - Tacrolimus for improved treatment of transplant patients (2014-03-04),

Veloxis Pharmaceuticals A/S is a biopharmaceutical company focusing on the development and commercialization of innovative products for the treatment of serious medical conditions. With a commitment to improving patient outcomes, Veloxis strives to address unmet medical needs through research, development, and strategic partnerships.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

24 Patents

#1 in København

#123 in Denmark

#25,835 in the World

København, Denmark

Veloxis Pharmaceuticals A/s

Forward Citations = 143

11 inventors:

Per Holm (22 out of 36 patents)

Tomas Norling (14 out of 22 patents)

Robert D Gordon (3 out of 15 patents)

4. Anne-Marie Lademann (3 out of 6 patents)

5. William J Polvino (2 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…